0001812191-23-000005.txt : 20230814 0001812191-23-000005.hdr.sgml : 20230814 20230814104433 ACCESSION NUMBER: 0001812191-23-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 EFFECTIVENESS DATE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alphageneron Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001812191 IRS NUMBER: 850531267 STATE OF INCORPORATION: DE FISCAL YEAR END: 1220 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489584 FILM NUMBER: 231167216 BUSINESS ADDRESS: STREET 1: 1441 BROADWAY, 3RD FLOOR STREET 2: STE #3159 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 6465695522 MAIL ADDRESS: STREET 1: 1441 BROADWAY, 3RD FLOOR STREET 2: STE #3159 CITY: NEW YORK STATE: NY ZIP: 10018 D 1 primary_doc.xml X0708 D LIVE 0001812191 Alphageneron Pharmaceuticals, Inc. 1441 BROADWAY, 3RD FLOOR STE #3159 NEW YORK NY NEW YORK 10018 6465695522 DELAWARE None None Corporation true 2020 Robert Brooks Harvard Square, One Mifflin Place Ste. 400 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Ola Soderquist 1441 Broadway 1441 Broadway New York NY NEW YORK 10013 Executive Officer Marc Lippman 1441 Broadway 3rd Floor, #3159 New York NY NEW YORK 10013 Director Bikash Verma 1441 Broadway 3rd Floor, #3159 New York NY NEW YORK 10013 Director Robert Clarke 1441 Broadway 3rd Floor, #3159 New York NY NEW YORK 10013 Director Graham Pockley 1441 Broadway New York NY NEW YORK 10013 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2023-06-20 false true false 0 250000 250000 0 false 1 0 0 0 false Alphageneron Pharmaceuticals, Inc. Robert Brooks Robert Brooks Chief Executive Officer 2023-08-11